IP Library Granted Patent US 8,679,818
Granted Patent B2
US 8,679,818 · App. 13/717,115 · Granted Mar 25, 2014

BGL7 beta-glucosidase and nucleic acids encoding the same

Inventors: Nigel Dunn-Coleman (El Sauzal, ES); Michael Ward (San Francisco, CA)
Assignee: Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,679,818
App. No.
13/717,115
Granted
Mar 25, 2014
Kind
B2
Abstract

The present invention provides a novel β-glucosidase nucleic acid sequence, designated bgl7, and the corresponding BGL7 amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding BGL7, recombinant BGL7 proteins and methods for producing the same.

Claims (20)

1. A substantially purified β-glucosidase 7 (BGL7) polypeptide with the biological activity of a β-glucosidase, comprising a sequence selected from the group consisting of:

(a) an amino acid sequence having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:2;

(b) an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:2;

(c) an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2; and

(d) the amino acid sequence of SEQ ID NO:2.

2. A detergent composition, said composition comprising a β-glucosidase 7 (BGL7) polypeptide with the biological activity of a β-glucosidase selected from the group consisting of:

(a) an amino acid sequence having at least 85% sequence identity to the amino acid sequence of SEQ ID NO:2;

(b) an amino acid sequence having at least 90% sequence identity to the amino acid sequence of SEQ ID NO:2;

(c) an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2; and

(d) the amino acid sequence of SEQ ID NO:2.

3. The BGL7 polypeptide of claim 1 , wherein said polypeptide is expressed in a host cell.

4. The BGL7 polypeptide of claim 3 wherein said host cell is a filamentous fungus or a yeast cell.

5. The BGL7 polypeptide of claim 4 , wherein said filamentous fungus cell is a cell of the group selected from Trichoderma sp.; Penicillium sp., Humicola sp., including Humicola insolens; Aspergillus sp., Chrysosporium sp., Fusarium sp., Hypocrea sp., and Emericella sp.

6. The BGL7 polypeptide of claim 3 , wherein said host cell is genetically modified.

7. The BGL7 polypeptide of claim 6 , wherein said modified host cell is modified to achieve an increase in BGL7 expression, a decrease or elimination in BGL7 expression, or expression of an altered form of BGL7.

8. The BGL7 polypeptide of claim 3 , wherein said polypeptide is native or heterologous to the host cell.

9. A BGL7 polypeptide produced by fermentation of the modified host cell of claim 6 .

10. A cellulase composition comprising a polypeptide of claim 1 .

11. The cellulase composition of claim 10 , wherein said polypeptide is present at about 1 to about 25 weight percent relative to any cellobiohydrolase or endoglucanse type components present in the cellulase composition.

12. The cellulase composition of claim 10 , wherein said composition is a fermentation culture.

Assignments (2)
CHANGE OF NAME Recorded Jun 3, 2013
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 030541/0289 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2013
From: DUNN-COLEMAN, NIGEL; WARD, MICHAEL
To: GENENCOR INTERNATIONAL, INC.
Reel/Frame 030541/0292 →
Continuity (4)
Division 13347347 · Jan 10, 2012
Division 12145023 · Jun 24, 2008
Division 10301015 · Nov 21, 2002
Related Publication 20130177965A1 · Jul 11, 2013